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Celiac disease is a life-long condition with significant morbidity and health-care costs (1). Conven-
tional understanding of etiopathological factors, specifically the roles played by theHLAgenes (DQ2
andDQ8), has greatly advanced in recent years. Furthermore, it is nowwell accepted that these HLA
genes contribute to an increased risk of celiac disease for first-degree relatives of those affected by the
condition. One such group is infants born to amother with known celiac disease. Current guidelines
for such high-risk infants include the recommendation to introduce gluten between 4 and 6months
of age and ideally, while still breastfeeding. Emerging data from a number of large studies refute the
basis for these recommendations, thereby necessitating a new approach.
Existing guidelines pertaining to gluten introduction are largely based on observational, ret-
rospective data. In 1980s, the Swedish epidemic of celiac disease occurred following a general
recommendation to delay the introduction of gluten to beyond 6months of age (2). The dramatic
increase in celiac diagnoses was halted in Sweden when this recommendation was revised so that
gluten was instead introduced at 4months of age. Subsequent evidence emerged showing that the
introduction of gluten, either prior to 3months or after 7months of age, increased the risk of celiac
disease (3).
Similarly, the advice to introduce gluten while infants were still being breastfed was in keeping
with the best available evidence, which suggested a negative association between duration of
breastfeeding and the development of celiac disease. A series of large prospective studies conducted
in recent years has now provided new evidence on which to base our management of these infants
at greater risk of celiac disease.
In a well-designed study conducted across multiple locations in Italy, Lionetti et al. (4) confirmed
that children with a high-risk HLA genotype (DQ2 or DQ8 positive) were more likely than those
with standard risk HLA genotype (DQ2 or DQ8 negative) to develop celiac disease autoimmunity.
Interestingly, following randomization to having gluten introduced at either 6 or 12months of age,
there was no difference in the rates of celiac disease autoimmunity or biopsy-proven celiac disease
between the groups. Results from this study did, however, demonstrate that delayed introduction
of gluten was associated with a later onset of disease. In this study, breastfeeding had no modifying
effect on subsequent development of celiac disease.
A further multicentre, double-blinded randomized controlled trial included children who were
either HLA-DQ2 or HLA-DQ8 positive and who had a first-degree relative with celiac disease (5).
Each arm was randomized to receive either a small amount of gluten or placebo at between 4 and
6months of age. This study reported no difference in the incidence of celiac disease between the
groups at 3 years of age. The authors’ also conclude that exclusivity or duration of breastfeeding
appeared to have no impact on celiac disease development in this cohort.
From the Netherlands, a nested subset of children who were either HLA-DQ2 or HLA-DQ8
positive within a population-based cohort study were retrospectively assessed with regards to
gluten introduction, breastfeeding, and the development of celiac disease (6). The findings aris-
ing from this study demonstrated that neither the delayed introduction of gluten to beyond
6months of age nor duration of breastfeeding of at least 6months had any effect on develop-
ing celiac disease autoimmunity. Similar to the Dutch study, a genetically high-risk sub-group
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within a multi-national birth cohort was followed up with regards
to risk factors for subsequent development of celiac disease (7). In
the latter study, gluten introduction either before 4months or after
6months of age appeared to have no effect on celiac disease risk.
By contrast, evidence from aNorwegian cohort study suggested
that introduction of gluten after 6months of age and breastfeeding
beyond 12months of age conferred additional risk for developing
celiac disease (8). It is important to note, however, that the cohort
in thisNorwegian studywas not stratified according to genetic risk
(unlike the previously referenced reports).
While each of the recent studies has provided useful evi-
dence, it is important to note that these reports have done
so by asking slightly different questions. The consensus, how-
ever, is clear – the approach to a first-degree infant of some-
one with celiac disease must change. Although it still appears
appropriate and important to introduce gluten-containing foods
in mid-infancy, the previous recommendation of coordinat-
ing this with ongoing breastfeeding is no longer valid. That
said, the myriad benefits of breastfeeding still hold true:
none of the presented evidence warrants changing advice in
this regard. While several aspects of the optimal manage-
ment of genetically susceptible infants are not known, these
recent studies at least necessitate revision of the current
recommendations.
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